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ARTICLE
DNA nanomapping using CRISPR-Cas9 as a
programmable nanoparticle
Andrey Mikheikin1, Anita Olsen1, Kevin Leslie1, Freddie Russell-Pavier2,3, Andrew Yacoot2, Loren Picco3,
Oliver Payton3, Amir Toor4,5, Alden Chesney5,6, James K. Gimzewski 7, Bud Mishra8 & Jason Reed1,5
Progress in whole-genome sequencing using short-read (e.g., <150 bp), next-generation
sequencing technologies has reinvigorated interest in high-resolution physical mapping to ﬁll
technical gaps that are not well addressed by sequencing. Here, we report two technical
advances in DNA nanotechnology and single-molecule genomics: (1) we describe a labeling
technique (CRISPR-Cas9 nanoparticles) for high-speed AFM-based physical mapping of DNA
and (2) the ﬁrst successful demonstration of using DVD optics to image DNA molecules with
high-speed AFM. As a proof of principle, we used this new “nanomapping” method to detect
and map precisely BCL2–IGH translocations present in lymph node biopsies of follicular
lymphoma patents. This HS-AFM “nanomapping” technique can be complementary to both
sequencing and other physical mapping approaches.
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Among the most important applications of DNA physicalmapping are structural variant detection and whole-genome haplotype assembly. Because of several earlier
probabilistic analyses (including our work on 0–1 laws1–3), it has
become clear that successful physical mapping technologies will
need to exceed certain thresholds in molecular length, coverage,
sizing accuracy, and marker speciﬁcity. Given this design
requirement, the ﬁeld urgently needs quantum leaps in both
super-resolution-microscopy technology and labeling chemistry.
Despite being invented in the mid-1990s, single-molecule
optical mapping has had only a limited impact on the ﬁeld of
human genomics compared to the more recently invented next-
generation sequencing, primarily because it lacks sufﬁcient reso-
lution to deal with structurally complex regions easily. We have
shown previously that marker localization must be extremely
precise (e.g., uncertainty <250 bp) to make single-molecule
alignment computationally straightforward1–3. While very large
contiguous maps can be generated with optical mapping, the
error in localizing individual features is large enough (e.g., ~2–5
kb) that relatively high-coverage depth (e.g., >100×) is required
to make it minimally workable. Even with this high coverage,
optical mapping often fails as a stand-alone method for assem-
bling high-complexity genomes. It is for this reason that the most
successful applications of that technique in human genomics have
been as a supplement to sequencing approaches (e.g., Illumina,
PacBio, etc.)4 It is possible that in time, “super-optical-resolution”
techniques (e.g., PALM, STORM, etc.) will transform optical
mapping. However, recent attempts to employ these methods rely
on protocols that remain to be proven as practical for general use
(lengthy, complex, etc.)5–7.
Nanopore technology, in theory, is capable of both base-by-
base sequencing, and long-range mapping of DNA structural
variants. However, the physics of the DNA–nanopore interaction
present some signiﬁcant barriers to analyzing long molecules, and
there are distinct advantages to working with longer, intact
molecules for haplotype phasing and bridging repeats. Unlike
optical mapping, nanopore techniques employ a “ﬁxed sensor,
mobile molecule” approach. Because long mobile DNA molecules
form random coils in solution, slow diffusion rates, and molecule
tangling are barriers to achieving long reads. While very long
nanopore reads (e.g., 50 kb+) have been demonstrated spor-
adically, this performance has proven to be difﬁcult to achieve
routinely. Further, these very long reads required library pre-
parations and have not been achieved with unmodiﬁed genomic
DNA. Recent work shows that nanopore DNA sequencing is
most effective when using molecules of <10 kb in length8, 9.
While this read length is considered to be long in the next-
generation sequencing ﬁeld, it is quite short for a physical map-
ping method. In comparison, the “imaging” approach to DNA
mapping (e.g., optical mapping10, ﬁber FISH11, DNA combing12,
etc.) uses ﬁxed, extended molecules. This lends itself well to
analyzing natural genomic DNA fragments of great size. For
instance, optical mapping easily handles single molecules as large
as ~300 kb13. Our work with AFM imaging has taken the “ﬁxed
molecule” approach, adopting the reproducible and well-known
imaging-ﬁeld protocols that are compatible with very long,
surface-supported molecules2, 14.
In this work, we use high-speed AFM (HS-AFM) to create
precise DNA single-molecule physical maps, and show scalability
by integrating consumer electronics (DVD optical pickup units).
To date, the impetus behind the ﬁeld of high-speed AFM devel-
opment has been the visualization and study of biomolecular
processes. The instruments designed to achieve this goal all
sacriﬁce sample versatility to provide a small (e.g., 1 × 1 µm)
window into the nanoscale15, 16. The lack of scalability of these
measurements prohibits their use in physical mapping, which
requires both high-data rates and wide-area coverage. In contrast,
our method for high-speed AFM directly addresses this need. It
follows design principles distinct from the rest of the ﬁeld:
operating in a high-speed contact mode, we sidestep bandwidth
bottlenecks and enable unprecedented rates of nanoscale
measurements.
To unlock the potential of HS-AFM-based “nanomapping”, we
developed Cas9 as a stable and speciﬁc “programmable
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Fig. 1 High-speed AFM measurement of Cas9-labeled DNA. a Cas9 labeling chemistry and sample preparation work ﬂow: (I) incubate target DNA with
Cas9–sgRNA and ﬁx with formaldehyde, (II) remove unbound Cas9–sgRNA complexes and deposit molecules on mica, and (III) image with HS-AFM and
measure locations of labels on DNA. b High-speed contact mode AFM, with a coffee mug for scale. The zoom-in view of the x–y ﬂexure scanner shows the
relative positions of the sample, cantilever, and laser vibrometer objective. c As conﬁgured, the HS-AFM produces two 16-bit, 1000 × 1000 pixel images
per second
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nanoparticle”. One very discovery, we report is the relative sta-
bility of the Cas9–sgRNA–DNA complex in the face of the harsh
perturbation generated by the AFM tip moving at linear speeds of
up to 10 mm/s. Previous work on DNA labeling with CRISPR-
Cas9 has focused on its properties and uses as an enzyme, which
is very different from our use of it as a “nanoparticle”. For
instance, in a recent optical mapping study, it served as a nicking
restriction enzyme, to create sites for secondary DNA polymerase
labeling with ﬂuorescent nucleotides17. Molecule fragmentation is
a major drawback of nicking-based labeling schemes. DNA with
closely spaced nicks (e.g., less than ~200 bp) is not stable, and will
not remain intact during processing. This problem impairs pre-
cisely locating translocation breakpoints, or localizing short
insertions or deletions. It also puts an upper bound on the
maximum length of the molecule, because very long molecules
will inevitably contain two nearby nicking sites. Using Cas9 as a
nanoparticle instead of a nicking enzyme avoids these draw-
backs15–17.
Results
Cas9 nanoparticle labeling. Figure 1a shows the Cas9 labeling
chemistry and sample work ﬂow. Target DNA is incubated with
Cas9–sgRNA and ﬁxed with formaldehyde to prevent dissocia-
tion of Cas9 from DNA during puriﬁcation. Unbound
Cas9–sgRNA complexes are removed, and the sample is depos-
ited on mica for HS-AFM imaging in air. Prior to imaging, the
sample is dried at 120○C, a step which improves imaging per-
formance and also likely reverses the formaldehyde ﬁxation18.
During imaging, the cantilever position is measured with a
Polytec compact laser Doppler vibrometer capable of capturing
2.5 million height measurements per second with a noise ﬂoor
below 200 pm. Piezo stick-slip motors below the scanner can
provide coarse positioning in x, y, and z, and permit imaging
anywhere within a 17 × 17-mm area of the sample. It can produce
two 16-bit, 1000 × 1000 pixel images per second. Scan sizes are
0.5–5-microns square (2 microns typical), yielding 0.5–5-nm
pixel sizes.
We used a positively charged surface for DNA ﬁxation, as the
behavior of this type of system in AFM imaging has been studied
extensively19–21. Although several methods can be employed to
charge the surface, and would work for our application,
magnesium ion-mediated deposition on freshly cleaved mica is
simple, rapid, and allows for accurate measurement of DNA
contour length. As shown by refs. 20, 22, the binding forces are
strong enough to irreversibly adsorb DNA molecules onto mica
surface but at the same time allowing for equilibration of DNA
molecules in two dimensions on the surface.
We demonstrated the efﬁciency and precision of Cas9 labeling
using several gene-speciﬁc sgRNAs targeted to BRCA1, HER2,
and TERT gene sequences (see Supplementary Fig. 1 for maps).
Cas9 formed sequence-speciﬁc complexes with sgRNA at high
efﬁciency (e.g., median 90% per site labeling rate), and labels were
localized on individual molecules with very high precision.
Figure 2a shows HS-AFM images of complexes of wild-type
Cas9–sgRNA with BRCA1 long-PCR amplicons (12,900 bp).
Bound globular particles are present on the DNA molecules in
close proximity to the expected target sequence locations. Note
that no signiﬁcant cleavage of DNA by wild-type Cas9 nuclease at
our experimental conditions was observed. To label the BRCA1
amplicon, we employed a single sgRNA that matches a subset of
naturally occurring Alu repeats in the genomic locus (see
Supplementary Fig. 2 for further exemplary images). In this case,
the labeling rate was ~90% for perfect sgRNA match sites and
50% at sites with a single mismatch. Alu repeats are the most
TERT
100 nm
a
* *
100 nm
0 kbp 6.44.81.8 6.7 9.0 10.1 12.9
0 μm 2.21.60.6 2.3 3.1 3.4 4.4
6800 bp 275 420
218
3 n
m
0 n
m
3 n
m
0 n
m
3 n
m
0 n
m
0 nm 84 134
HER2
100 nm
6450 bp 164 521
2070 nm 53 166
BRCA1
b c
1.
2.
3.
1.
2.
3.
1. 2. 3. 1. 2. 3.
1.4
0.5
Fig. 2 sgRNA–Cas9 complexes on DNA. aMap and the corresponding HS-AFM image of Cas9-labeled BRCA1 amplicon. Red tick marks on the map indicate
locations of the Alu repeat-targeted sgRNA-binding sites. In the image, sgRNA–Cas9 protein complexes appear as 3-nm-tall bumps on the DNA backbone.
The amplicon sequence includes ﬁve perfect matches to the 20-bp sgRNA sequence and ﬁve single base-pair mismatches. Single base-pair mismatches
label at roughly one-half the frequency of perfect matches. The star (*) indicates Cas9 bound at locations with a single mismatch, while all other locations
are perfect matches. b, c Cas-9-labeled TERT and HER2 amplicons. The sharp bend induced in the DNA backbone by the sgRNA–Cas9 complex is evident in
both examples
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abundant repetitive element in the human genome, making up
10% of the total nucleotide sequence. As such, Alu repeats are
convenient, densely spaced targets for CRISPR-Cas9 mapping.
For example, 42% of the tumor suppressor gene BRCA1 sequence
consists of Alu repeats23. Moreover, Alu repeats mediate some
cancer-related genome variations, including deletions or duplica-
tions of exons in BRCA124–28.
Figure 2b, c show sequence maps and the corresponding HS-
AFM images of singly- and doubly labeled TERT (680 bp), and
HER2 (645 bp) constructs. Custom sgRNAs were created to label
these constructs for the purposes of accurately determining
positioning accuracy and labeling kinetics. For the TERT
amplicon, two unique sgRNAs were tested independently and
in combination; for HER2, ﬁve unique sgRNAs were tested
independently and in combination. The labeling was highly
efﬁcient, with over 90% of the expected sites containing a Cas9
label (median 94%, range 89–99%). One sgRNA species exhibited
an unusually low initial labeling rate (35%); this was improved to
87% by increasing the sgRNA concentration to threefold vs.
standard conditions. This result suggests that many DNA
sequences containing a GG motif can be targeted with proper
reaction optimization. Off-target binding, deﬁned as labels >2 s.d.
from their expected location, was quite low and did not exceed
6% on a per-site basis. However, the off-target binding rate
depends on experimental conditions (i.e., concentration of Cas9
and sgRNA) and can also be optimized. Labeling efﬁciency values
for the different sgRNAs are presented in Supplementary Table 1.
The spatial resolution of labeling, i.e., the precision of location
of the label on DNA molecule, is a critical parameter in DNA
mapping (see e.g., Anantharaman et al.1 or Anantharaman
et al.3). As shown in Fig. 3a, the HS-AFM positional measure-
ments were highly accurate in an absolute sense and linear over
the measured range of 100–4550 bp. In addition to long-range
mapping applications (e.g., sequence assembly, detecting struc-
tural variants, etc.), there are many potential applications
requiring precise sizing of short DNA molecules (e.g., smaller
than 300 bp). For example, short-tandem repeat-based genetic
ﬁngerprinting requires the ability to distinguish 2–4 bp length
differences in PCR amplicons of ~200 bp total length. To test the
ability to distinguish such small size differences, we measured a
ladder series of 140–150 bp PCR amplicons, labeled at both ends
with Cas9. As shown in Fig. 3b, we reliably discriminate 2 bp
differences in these amplicons by pooling measurements from a
large number of identical molecules (~15,000 counts per species).
Notably, the image quality was sufﬁciently good to allow online,
real-time image processing. We are not aware of another AFM
technology with the throughput required to make these kinds of
measurements in a timely fashion. Other potential applications
include measuring spatial properties and conformational changes
of A-, B-, Z,- and other forms of duplex DNA and noncanonical
DNA structures such as triplexes, quadruplexes, and four-way
junctions of various sequence composition at different experi-
mental conditions (pH, temperature, ions, etc.). Cas9-labeled
DNA molecules could be employed as a highly sensitive biosensor
to detect the presence of DNA-speciﬁc agents (small molecules,
DNA adducts, DNA-speciﬁc proteins, histones, etc.).
BCL2–IGH translocation mapping. An important potential
application of “nanomapping” could be detecting cancer-related
structural variants of diagnostic and prognostic signiﬁcance. In
the clinical lab, ﬂuorescent in situ hybridization (FISH) and PCR
remain the mainstays29; unfortunately, they fail in a signiﬁcant
fraction of cases, either due to insufﬁcient resolution (FISH) or
the fact that the vast majority of structural variant breakpoints are
scattered widely and thus cannot be localized a priori for
ampliﬁcation by PCR30. While microarrays can improve the
detection of copy number variations, they are not a replacement
for FISH, for example, because they cannot detect unlocalized
balanced translocations.
As shown in Fig. 4, we assessed the feasibility of using Cas9-
HSAFM mapping to detect the BCL2–IGH translocation
associated with follicular lymphoma, caused by aberrant V(D)J
recombination31, 32. We chose this example because it is common
in lymphoma, and likely to be present in easily obtained frozen
tissue shavings. The breakpoints for this translocation are well
characterized and serve as a reference for validating the accuracy
and reproducibility of the results using this technique in clinical
samples, such as bone marrow and lymph node biopsies. These
breakpoints occur adjacent to the Ig heavy-chain J-region (JH) or
adjacent to the junction of the heavy-chain D-region and J-region
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Fig. 3 HS-AFM accurately localizes sgRNA–Cas9 complexes on DNA. a Measured vs. expected position of the Cas9 labels determined for BRCA1, TERT-
HER2, and ladder constructs. Error bars represent the 95% conﬁdence interval of the mean. For the TERT-HER2 and ladder data points, the symbol diameter
is larger than the 95% conﬁdence interval span. The expected size and sample standard deviation (σ) are indicated at three points for reference. b Sizing
closely spaced ladder constructs, end-labeled with Cas9. Vertical red lines inside symbols represent the 95% conﬁdence interval of the mean. See Methods
for measurement detail
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(DHJH). The majority of the corresponding breakpoints in BCL2
(e.g., about 60% of cases) occur in a hotspot known as the major
breakpoint region (MBR)30, making this region a convenient
target for our tests.
We designed sgRNAs targeting the JH elements in IGH and the
MBR region of BCL2. Figure 4a shows the labeling scheme and
the corresponding images of wild-type BCL2 and unrearranged
IGH obtained from human germ line DNA. Using the Cas9
labels, we mapped a known BCL2–IGH translocation present in
the follicular lymphoma cell line DOHH-2, obtained commer-
cially, and detected similar translocations in seven lymph node
tissue samples from follicular lymphoma patients (Fig. 4c). In
doing so, we employed very closely spaced markers (tens of
nanometers) that are well distinguished—a capability beyond
what is possible with any form of optical mapping, including
super-resolution optical methods33, 34.
Imaging DNA with DVD optical pickup unit-enabled HS-
AFM. We demonstrated the scalability of HS-AFM design by
replacing the laser vibrometer, by far the most complex hardware
component, with an off-the-shelf DVD player optical pickup unit
(OPU)33. The OPU detector and its placement above the scan
stage is shown in Fig. 5a, b, respectively. The OPU module uses
an astigmatic focusing scheme to sense the vertical displacement
of the HS-AFM cantilever: the image of the tightly focused laser
spot changes the shape on the quadrant photodiode detector as
the cantilever is moved vertically (see Supplementary Fig. 4).
Nanometer displacement sensitivity is achievable by the OPU
without modiﬁcation, using a simple battery power source to
minimize electronic noise. The OPU has onboard voice coil
actuators to focus the detection beam, and possesses integrated
laser control electronics and high-bandwidth (e.g., >10MHz)
signal ampliﬁers, making it ideal for rapid, high-precision dis-
placement sensing. The OPU HS-AFM produced images of
similar size, resolution, and quality as the vibrometer, although at
a lower frame rate (0.5–1 frames per second (fps)). As shown in
Fig. 5c, d, the Cas9 labels are clearly resolved, as is the DNA
backbone in some cases, indicating that the noise ﬂoor is at or
slightly below the apparent level of the DNA height under these
conditions (roughly 300 pm). We determined Cas9 intra-label
spacing on doubly labeled TERT and HER2 amplicons with
accuracy and precision was equivalent to that achieved with the
laser vibrometer (Fig. 5e). The median center-to-center spacing
between the two TERT markers was 47.7 nm (s.d. 8.1 nm) vs.
46.9 nm expected; and for HER2, it was 108.2 nm (s.d 17.1 nm)
vs. 114.1 nm expected.
With no modiﬁcations, this OPU HS-AFM can be used to
detect and measure length polymorphisms between closely spaced
markers (e.g., closer than about 400 bp). Alternatively, multiple
Cas9 labels can be used as simple single-molecule barcodes,
making the technology useful in counting applications such as
detecting gene copy number variation, digital PCR, or transcrip-
tional proﬁling. Achievable improvements in signal-to-noise and
drift compensation34 will allow the OPU to reliably detect the
DNA backbone as well as the Cas9 labels. Moreover, OPUs have
typical detection bandwidths of 80–400MHz (e.g., BluRay),
meaning that if higher sampling rate digitization electronics are
used, the pixel rate of an OPU-based instrument can be increased
from 2MS per second used here to as high as 80 or even 400-
million samples per second, depending on the OPU model used.
By increasing the scan speed and image size, these higher pixel
rates can be translated into measurement throughput directly.
Discussion
The nanomapping technique described here can be com-
plementary to both sequencing and other physical mapping
approaches. It will be necessary to develop workable protocols to
label and elongate molecules larger than 13,000 bp, if nanomap-
ping is to become practically useful for de novo structural variant
detection and sequence alignment applications. In principle, one
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Fig. 4 Mapping BCL2–IGH translocations with Cas9. a Maps of PCR amplicons from wild-type BCL2 and IGH with Cas9 labels (different colors for
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could isolate longer molecules by methods such as hybrid capture,
gel extraction, centrifugation, immunoprecipitation, etc. These
longer DNAs could be stretched linearly for genomic mapping
using well-established DNA elongation methods such as micro-
or nanochannels, pressure and electrokinetic ﬂow devices, or laser
and magnetic tweezers.
It may be possible to combine HS-AFM nanomapping with
hybrid capture or “inverse” long PCR, for instance, to isolate
translocations breakpoint regions using only limited knowledge
of the loci involved in the translocation35, 36. Breakpoint position
and identity of the translocation partners would be resolved by
“molecular barcoding” with CRISPR-Cas9. In the BCL2–IGH
mapping experiments, we did not examine the histology of the
lymph node tissues, so we do not know the fraction of B cells
harboring the translocation. This sample type would be expected
to contain a signiﬁcant number of cancerous cells, all of which
would have the translocation. We used long-range PCR to pre-
pare the DNA molecules and thus, only the translocated locus
would be ampliﬁed. Under these conditions, we would expect to
detect even relatively rare instances (e.g., cancer cells present at
1% abundance or greater).
For loci that can be effectively sampled with long PCR, or with
an ensemble of long PCR amplicons, this strategy is likely to be
effective in detecting rare species present at 1% abundance or
greater. Hybrid capture methods combined with throughput-
optimized hardware and software are likely to be the most gen-
erally effective approach. This is in fact the method used for most
NGS diagnostic panels and whole-exome sequencing assays (e.g.,
Agilent SureSelect capture baits, etc.). In that case, both mutant
and normal sequences would be present in the sample, and thus,
the limit of detection becomes a function of sampling depth.
Given the throughput achieved in this study, it is reasonable to
project that the loci of several hundreds of kilobases can be
sampled at a sufﬁcient depth to detect mutants present at 10%
fraction.
The data presented in Fig. 3 or Supplementary Tables 4–7,
allow us to estimate the trade-off between time and resolution
with the system, as implemented. For a single 12.9-kb BRCA1
molecule, the inter-Cas9 spacing is measured to a median pre-
cision of roughly ±100 bp s.d. The ﬁeld of view is roughly
2.5 μm× 2.5 μm, and the achievable frame rate is 4 fps. Two
overlapping frames are required to capture the entire BRCA1
molecule. This gives a very rough estimate of the time required to
capture one such molecule at ±100-bp marker resolution: 0.5 s.
For smaller molecules (100–300 bp), the median resolution for a
single molecule is 20 bp. It is typically possible to capture between
10 and 100 such molecules per frame.
Throughput could be increased by (1) increasing the number of
molecules per frame, using various ﬂow alignment techniques to
increase packing density, (2) expanding the ﬁeld of view to the
maximum supported 5 × 5 μm, and increasing the digitization
rate accordingly, to retain pixel size, and (3) employing multiple
cantilevers simultaneously on the same sample. A multiprobe
cantilever chip is not strictly required. Since only a tiny fraction of
the area of the sample is interrogated, it can be easily split and
measured on spatially separated detector–cantilever pairs,
assuming that the detector and digitizer used is relatively inex-
pensive, such as is the case for the DVD OPU.
While DVD OPUs have been used as displacement sensors in
AFM previously, the combination with high-speed AFM pre-
sented here is new. An examination of the state of the ﬁeld
suggests that in a number of respects, our implementation
exceeds the current state of the art. Our passive mechanical
feedback implementation of high-speed “contact mode” with
OPU detection is unique, as are the much higher imaging rates
achieved, and the much larger measurement areas demonstrated.
Because of these features, our DVD OPU implementation
uniquely enables a large number of measurements of DNA
molecules, which in turn makes possible entirely new statistical
analyses of molecule conformation, counting rare species, preci-
sion length measurements, etc.
Although DVD optics were ﬁrst implemented in AFMs in
199933 the ﬁeld of high-speed AFM is much more recent and
here, we present the results collected at a speed 10,000× faster
than comparable implementations37. In a previous publication, it
was shown that OPUs can act as a detection system in AC or
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“tapping” mode AFM to image DNA with scan rates of 0.2 lines
per second at pixel dimensions of 256 × 25637. In comparison, the
method that we presented could perform AFM on a unit area to
matching pixel densities 10,000 times at the same time compared
to the previously reported technique.
In a separate publication by the same group38 detailing
improved scan rates, tip velocities are achieved of up to 1.4 mm/s.
This compares well to our presented method which achieves scan
rates of up to 16 mm/s. However, this previous work utilized an
unusual 5-MHz-frequency cantilever, whereas our system oper-
ates with a mass-produced contact-mode cantilever. In addition,
in the prior work, the stage is speciﬁed to have a maximum
measurement area of up to 17 μm by 17 μm, whereas with our
presented method, a 2 cm by 2 cm area is addressable. This
improvement corresponds to a 700,000 times increase in mea-
surement area.
Finally, the previous OPU implementations utilizing tapping or
AC mode AFM39 are inherently rate limited by the oscillation of
the cantilever to pixel rates at a fraction of the oscillation fre-
quency (typically <500k pixels per second). Therefore, in these
implementations, it is not possible to access OPUs’ ultrahigh
bandwidth, capable of measurement rates up to several 100 s of
MHz, for high-speed AFM. While with our presented method of
high-speed contact-mode AFM, with no reliance on the resonant
frequency, no such mechanical upper limit has yet been found; in
our case, the limit is set by the digitization of the detection sys-
tem. Therefore, this technology presents an exciting possible
opportunity to increase high-speed AFM to even higher physical
measurement rates, allowing for both better spatial resolution and
frame rates.
While this tremendous speed increase is an essential difference,
it is not the only one. We operate our instrument in a water-
layer-mediated imaging mode that is unique to our instrument
and critical to making measurements at very high scan rates40.
Finally, here, we report how by combining large-travel coarse
positioners and small high-speed scan stage, the technology
enables measurements to be rapidly collected from the entire
surface of the sample, rather than the much smaller areas typical
of AFM. These design decisions make our instrument stand out,
to the best of our knowledge, against the body of AFM devel-
opment to date.
Methods
Reagents. All primers and sgRNA were purchased from Integrated DNA Tech-
nologies. For sequences, see Supplementary Table 2. SgRNA was prepared
according to the manufacturer’s recommendations. Wild-type Cas9 protein was
purchased from New England Biolabs, and Cas9 (D10A) nickase and dCas9 (D10A
and H840A) were purchased from Novateinbio.
DNA constructs. Supplementary Fig. 1 shows maps of the constructs indicating
the position of the Cas9 labels. For HER2 and TERT, primers were designed with
Primer Blast software, while primer sequences for BRCA1 were taken from Jia
et al.41. PCR solutions for HER2 and TERT amplicons contained 200 nM primers
(each), 100 ng of human genomic DNA: female (Promega) and 1× of LongAmp
Hot Start Taq 2× Master Mix (New England Biolabs) in 20- microl reaction
volume. Ampliﬁcation protocol for HER2 and TERT was initial denaturation at 95 °
C for 30 s, 35 cycles: 94 °C for 30 s, 60 °C for 30 s, and 68 °C for 2 min, followed by
ﬁnal extension at 68 °C for 5 min. For BRCA1, PCR solution composition and
ampliﬁcation protocol were the same as described in Jia et al.41 (PrimeSTAR GLX
DNA Polymerase, Takara). All amplicons were puriﬁed with Agencourt Ampure
XP magnetic beads (Beckman Coulter Life Sciences), eluted in TE buffer and
quantiﬁed either with Qubit dsDNA HS Assay or Qubit dsDNA BR Assay kit (Life
Technologies).
For the BRCA1 amplicon, Alu-family repeats containing the necessary GG
sequence to be used as a PAM site were identiﬁed with RepeatMasker software.
Using BLAST software, we found ﬁve perfect and ﬁve 1- or 2-base mismatched
sites to the chosen sgRNA sequence (designated as Alu-sgRNA in Supplementary
Tables 2 and 3).
As described in Supplementary Fig. 3, the ladder amplicons were synthesized
with Alu-targeted sgRNA at the ends using probes to introduce the recognition and
primer sites. PCR solutions for ladder amplicons contained 400 nM of Ladder-
Primer (the same primer is used as forward and reverse), 40 nM of Ladder-Probe,
1 ng of BRCA1 amplicon, and 1× of LongAmp Hot Start Taq 2× Master Mix (New
England Biolabs, Woburn, MA) in 20-microl reaction volume. Ampliﬁcation
protocol for ladder amplicons was initial denaturation at 95 °C for 30 s, probe
annealing, and extension at 50 °C for 5 min, 35 cycles: 94 °C for 30 s, 60 °C for 30 s,
and 68 °C for 1 min followed by ﬁnal extension at 68 °C for 5 min. The ladder
amplicons were puriﬁed and quantiﬁed using the same protocol as other
amplicons. Labeling was done with Alu-sgRNA using a standard labeling protocol.
Labeling reaction. The protocol is based on in vitro digestion of DNA with Cas9
protocol (New England Biolabs). EDTA was added to avoid cleavage of DNA, and
the concentrations of Cas9 and sgRNAs were increased to improve the labeling
rate. After labeling, Cas9-DNA complexes were ﬁxed with formaldehyde, and the
unbound protein was removed with a magnetic bead-based puriﬁcation system. A
concentration at 400 nM of each sgRNA was incubated with 200 nM of Cas9
protein in 1× Cas9 Nuclease Reaction buffer (New England Biolabs) supplemented
with 50 mM EDTA (pH= 8.0) at room temperature for 10 min; next, amplicons
were added to a ﬁnal concentration of 5 ng/μl and incubated at 37 °C for 1 h; next,
formaldehyde was added to a ﬁnal concentration of 1% and incubated at room
temperature for 10 min; next, TRIS (pH= 7.6) was added to a ﬁnal concentration
of 750 mM and the labeled amplicons were puriﬁed with Agencourt Ampure XP
magnetic beads (Beckman Coulter Life Sciences). We used Ampure magnetic beads
instead of spin columns, though both are effective. We had previously found
contamination in some manufacturer’s spin columns but not in Ampure, and thus
gravitated to the latter42. The role of formaldehyde cross-linking is to prevent
dissociation of Cas9 from DNA during puriﬁcation, which precedes heating and
imaging. We believe that it is very unlikely that Cas9 is covalently attached to DNA
during HS-AFM imaging. Our deposition protocol includes 10 min incubation of
deposited Cas9-DNA complexes at 120 °C followed by slow cooling, whereas for-
maldehyde cross-linking is reversed completely at 90 °C for 1 h or at 95 °C for 30
min18, 43. The role of formaldehyde cross-linking is thus to prevent dissociation of
Cas9 from DNA during puriﬁcation, which precedes heating and imaging. These
data suggest the unique properties of Cas9 to form a stable, slowly dissociating
tertiary complex with sgRNA and DNA.
High-speed AFM sample preparation and imaging. For HS-AFM sample pre-
paration (all samples except BRCA1), imaging, and data analysis, we used a pre-
viously developed experimental protocol2, 42. One microliter of 100 ng/μl solution
of the amplicons in deposition buffer (10 mM TRIS, 10 mM MgCl2, pH= 7.6) was
deposited on freshly cleaved mica surface, incubated for 1.5 min in a humid
environment, rinsed three times with 200 μl of MQ water, baked at 120 °C for 20
min, and cooled down to 40 °C in an oven.
Elongation of long DNA. This procedure was used for the BRCA1 long PCR
amplicons. A rectangular-shaped channel of 2–3-mm width was drawn on freshly
cleaved mica with a marker. One-half of a microliter of labeled DNA in deposition
buffer was deposited at the bottom of the channel, and the mica disk was imme-
diately rotated by 180° along a horizontal axis, causing the sample droplet to ﬂow
over the surface due to gravity. The disk was washed three times with 200 μl of MQ
water, baked at 120 °C for 10 min, and left in an oven until the temperature reached
40 °C.
BCL2–IGH fusion sample preparation. Follicular lymphoma cell line DOHH-2
was purchased from Leibniz-Institut DSMZ—Deutsche Sammlung von Mikroor-
ganismen und Zellkulturen GmbH. De-identiﬁed follicular lymphoma patient
samples were obtained from the VCU Tissue and Data Analysis Core Laboratory.
Patient samples were obtained from patients who gave informed consent. This
tissue was provided by the VCU Tissue and Data Analysis Core Laboratory
(TDAAC), which collects residual tumor tissues and blood under an IRB-approved
protocol (VCU IRB #HM2471). The sequence for MBR-02 and Eμ-01 primers was
taken from Akasaka et al.44, and other primers were designed with Primer Blast
software. MagAttract HMW DNA kit (QIAGEN) was used to extract genomic
DNA from clinical samples according to the manufacturer’s protocol. The
extracted DNA was quantiﬁed with Qubit BR or HS assays (Life Technologies).
PCR solution contained 40 ng of template (clinical sample for gene fusion or
human genomic DNA: female (Promega) for wild-type BCL2 and IGH controls),
400 nM of each primer (for primer sequences, see Supplementary Tables 8 and 9),
1.6 μl of dNTP mix (2.5 mM of each in stock solution), 0.4 μl of PrimeSTAR GXL
DNA polymerase (Takara Clontech), and 4 μl of 5x PrimeSTAR GXL buffer in 20-
μl volume. Forty cycles: 10 s at 98 °C and 10 min at 68 °C were conducted (the
protocol is based on Jia et al.41). Amplicons were puriﬁed with AMPure XP pur-
iﬁcation solution (Beckman Coulter) and quantiﬁed with Qubit BR or HS assays
(Life Technologies). Labeling of gene fusions and control was performed with a
standard labeling protocol with Cas9 concentration increased to 400 nM and MBR-
BCL2-L gRNA was at 1200 nM.
HS-AFM. The system used in this work was a custom prototype which utilized a
very low spring constant triangle cantilever (Bruker Nano, MSNL, 0.01–0.03 N/m
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spring constant) operating in contact mode with no z-feedback. The cantilever
vertical deﬂection was measured by a 2.5-MHz-bandwidth laser Doppler vib-
rometer (Polytec) using a height decoder module45. The sample was translated in
the fast (1000 Hz) and slow (1–4 Hz) scan directions by a piezo-actuated ﬂexure
stage capable of 5 μm deﬂection in both axes. Typically, images of size 2 × 2 μm,
1000 × 1000 pixels, were captured in raster mode and rendered using customized
LabView software45. The high-speed ﬂexure stage was mounted on a stick-slip x–y
positioner for coarse alignment (Smaract, Inc.).
AFM data processing. An image-processing program developed for this appli-
cation, called AFMExplorer, analyzed images46. The image-processing pipeline is as
follows: AFM images are ﬂattened and preﬁltered to reduce noise, followed by
adaptive thresholding based on pixel height to recognize regions corresponding to
DNA molecules; a binary skeletonization procedure is used to determine the best
backbone contour for each molecule, and the molecule length in nanometers is
calculated by a cubic spline ﬁt to the backbone pixel set. An additional feature was
recently added for particle label recognition. This feature detects the height change
on the backbone of the molecule due to each CRISPR label and calculates the
length in nanometers of the distance from one end of the molecule to the label site.
In the case of more than one label, the measurements are continued to each
additional site.
BRCA1 amplicons spanned multiple overlapping frames; composite images
were created before analysis by stitching individual frames into a single larger
image, using the known displacement between frames. For HER2 and TERT
molecules, in a minority of instances (e.g., fewer than 20% of images), the program
was manually queued to correct or ignore automation errors; otherwise, the
molecule identiﬁcation and measurement is fully automatic. All ladder series
measurements were fully automated.
Supplementary Tables 4–7 show measurement detail and statistics for the
various constructs. The canonical solution value 2.94 bp/nm was used to convert
contour lengths measured in nanometers. Values for the median and s.d. were
determined from a Gaussian ﬁt to the population data. For the BRCA1 data,
lengths are measured between the center of the Cas9 labels appearing at perfect
sgRNA match sites. For the TERT and HER2 data, lengths to the center of the Cas9
markers are measured from the molecule’s unlabeled 5′ end (left end in
Supplementary Fig. 1). The ladder constructs were labeled at the ends, and contour
lengths were measured center to center between markers.
Statistical analysis of labeling rate. The full length of the molecule and the
distance from one end of the molecule to the label of focus were used to bisect the
molecule into a shorter and longer segment. The proportion of the full length
represented by the segment of interest is the target sequence. The theoretical
expected value of proportion can also be determined with this method using
expected measurements of full length and site location. Proportions are bounded at
0 and 1, and are typically analyzed by transforming them into logit form deﬁned as
logit ¼ ln p
1 p
 
The logit is the natural log of the long-segment proportion divided by the pro-
portion’s complement (one minus the proportion). This allows traditional linear-
ized distribution statistics including means, standard deviations, and conﬁdence
intervals based on the logits. The means and the lower and upper limits of the logit-
scale conﬁdence intervals can then be back-transformed through exponentiation
using
p^ ¼ e
logit
1þ elogit
The percent of outliers for the 95% conﬁdence interval of each label site is shown in
Supplementary Table 1.
Data availability. All relevant data are available from the authors upon request.
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